Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization: Two-year Outcomes from the Randomized BIOFLOW V Trial

被引：0
|
作者：
Kandzari, David [1 ]
Koolen, Jacques J. [2 ]
Doros, Gheorghe [3 ]
Massaro, Joseph [4 ]
Garcia-Garcia, Hector [5 ]
Bennett, Johan [6 ]
Roguin, Ariel [7 ]
Gharib, Elie [8 ]
Cutlip, Donald [9 ]
Waksman, Ron [5 ]
机构：
[1] Piedmont Heart Inst, Atlanta, GA USA
[2] Catharina Hosp, Eindhoven, Netherlands
[3] Baim Inst Clin Res, Boston, MA USA
[4] Boston Univ, Sch Publ Hlth, Boston, MA USA
[5] MedStar Washington Hosp Ctr, Washington, DC USA
[6] Univ Hosp Leuven, Leuven, Belgium
[7] RAMBAM, Haifa, Israel
[8] Charleston Area Med Ctr, Charleston, WV USA
[9] Baim Inst Clin Res, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 72卷 / 13期
关键词：
D O I：
10.1016/j.jacc.2018.08.1313
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-195
引用
收藏
页码：B83 / B83
页数：1
相关论文
共 50 条
  • [31] Unselected use of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for coronary revascularization
    Yamaji, Kyohei
    Zanchin, Thomas
    Zanchin, Christian
    Stortecky, Stefan
    Pilgrim, Thomas
    Heg, Dik
    Windecker, Stephan
    Raber, Lorenz
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B265 - B266
  • [32] Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
    de Winter, Robbert J.
    Zaman, Azfar
    Hara, Hironori
    Gao, Chao
    Ono, Masafumi
    Garg, Scot
    Smits, Pieter C.
    Tonino, Pim A. L.
    Hofma, Sjoerd H.
    Moreno, Raul
    Choudhury, Anirban
    Petrov, Ivo
    Cequier, Angel
    Colombo, Antonio
    Kaul, Upendra
    Onuma, Yoshinobu
    Serruys, Patrick W.
    [J]. EUROINTERVENTION, 2022, 18 (06) : 492 - +
  • [33] A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents
    Han, Yaling
    Xu, Bo
    Fu, Guosheng
    Wang, Xiaozeng
    Xu, Kai
    Jin, Chongying
    Tao, Ling
    Li, Lang
    Hou, Yuqing
    Su, Xi
    Fang, Quan
    Chen, Lianglong
    Liu, Huiliang
    Wang, Bin
    Yuan, Zuyi
    Gao, Chuanyu
    Zhou, Shenghua
    Sun, Zhongwei
    Zhao, Yanyan
    Guan, Changdong
    Stone, Gregg W.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (03) : 261 - 272
  • [34] Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization
    Yamaji, Kyohei
    Zanchin, Thomas
    Zanchin, Christian
    Stortecky, Stefan
    Koskinas, Konstantinos C.
    Hunziker, Lukas
    Praz, Fabien
    Bloechlinger, Stefan
    Moro, Christina
    Moschovitis, Aris
    Seiler, Christian
    Valgimigli, Marco
    Billinger, Michael
    Pilgrim, Thomas
    Heg, Dik
    Windecker, Stephan
    Raeber, Lorenz
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (09)
  • [35] Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents Prespecified Subgroup Analysis of the BIOSCIENCE Trial
    Franzone, Anna
    Pilgrim, Thomas
    Heg, Dik
    Roffi, Marco
    Tueller, David
    Vuilliomenet, Andre
    Muller, Olivier
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Jamshidi, Peiman
    Raeber, Lorenz
    Stortecky, Stefan
    Wenaweser, Peter
    Jueni, Peter
    Windecker, Stephan
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (06)
  • [36] Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
    Jafaripour, Iraj
    Ramezani, Mir Saeid
    Amin, Kamyar
    Amiri, Naghmeh Ziaie
    Goudarzi, Mohammad Taghi Hedayati
    Elhaminejad, Fahimeh
    Ahangar, Hemmat Gholinia
    [J]. CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (03) : 507 - 512
  • [37] Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial
    Li, Chongjian
    Yang, Yuejin
    Han, Yaling
    Song, Dan
    Xu, Jing
    Guan, Changdong
    Gao, Runlin
    Garcia-Garcia, Hector M.
    Waksman, Ron
    Xu, Bo
    [J]. CLINICAL THERAPEUTICS, 2020, 42 (04) : 649 - +
  • [38] Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial
    Slagboom, Ton
    Toelg, Ralph
    Witzenbichler, Bernhard
    Haude, Michael
    Masotti, Monica
    Salmeron, Rafael Ruiz
    Witkowski, Adam Ryszard
    Uematus, Masaaki
    Takahashi, Akihiko
    Waksman, Ron
    Satio, Shigeru
    [J]. EUROINTERVENTION, 2023, 18 (14) : 1197 - +
  • [39] Outcomes of patients treated with a biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stents after rotational atherectomy
    Mankerious, Nader
    Hemetsberger, Rayyan
    Traboulsi, Hussein
    Toelg, Ralph
    Abdel-Wahab, Mohamed
    Richardt, Gert
    Allali, Abdelhakim
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (10) : 1574 - 1585
  • [40] An abluminal biodegradable polymer sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients undergoing coronary revascularization: 3-year clinical outcomes of a randomized non-inferiority trial
    Zhang, Haijun
    Zhang, Xiaoping
    Yin, Yuxia
    Zhou, Chao
    Deng, Wei
    Zhang, Junwei
    Hou, Wenbo
    Lu, Shoutao
    Song, Caixia
    Cui, Xiaoshan
    Wang, Shenguo
    Yang, Fei
    Liu, Guang
    Duan, Cuihai
    Ge, Junbo
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
12345